Paula Suanzes

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Granulocytic Myeloid-Derived Suppressor Cells Sustain HIV Reservoirs by Inhibiting Viral Reactivation via Arginase-1-Mediated Mechanisms.

Granulocytic Myeloid-Derived Suppressor Cells Sustain HIV Reservoirs by Inhibiting Viral Reactivation via Arginase-1-Mediated Mechanisms.

Journal: JCI insight

Published: July 21, 2026

Humoral Immunogenicity of SARS-CoV-2 mRNA Primary Vaccination Among People with HIV.

Humoral Immunogenicity of SARS-CoV-2 mRNA Primary Vaccination Among People with HIV.

Journal: Microorganisms

Published: March 06, 2026

Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir.

Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir.

Journal: The Journal of infection

Published: January 21, 2026

Where did they go? Describing and reengaging people with HIV lost to follow-up in the PISCIS Cohort Study.

Where did they go? Describing and reengaging people with HIV lost to follow-up in the PISCIS Cohort Study.

Journal: AIDS care

Published: August 18, 2025

Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).

Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).

Journal: The Journal of infection

Published: May 19, 2025

Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.

Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.

Journal: Nature communications

Published: October 31, 2024

Effectiveness of Electrocautery, Topical Cidofovir, and Topical Sinecatechins for the Treatment of Anal High-Grade Squamous Intraepithelial Lesions in Persons With HIV: An Open-Label, Randomized Controlled Trial.

Effectiveness of Electrocautery, Topical Cidofovir, and Topical Sinecatechins for the Treatment of Anal High-Grade Squamous Intraepithelial Lesions in Persons With HIV: An Open-Label, Randomized Controlled Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 18, 2024

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.

Journal: Communications biology

Published: September 04, 2024

Developing and validating a clinical risk score to predict losses in the PISCIS cohort of people with HIV.

Developing and validating a clinical risk score to predict losses in the PISCIS cohort of people with HIV.

Journal: International journal of STD & AIDS

Published: August 15, 2024

NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control.

NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control.

Journal: JCI insight

Published: June 11, 2024

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration.

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 21, 2024

Effectiveness of trichloroacetic acid versus electrocautery for the treatment of anal high-grade squamous intraepithelial lesions in persons with HIV.

Effectiveness of trichloroacetic acid versus electrocautery for the treatment of anal high-grade squamous intraepithelial lesions in persons with HIV.

Journal: Infectious diseases (London, England)

Published: January 13, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026